Gastrointestinal Stents Market Growth, Size, Share, Analysis, Opportunity, and Forecast 2023-2028

Gastrointestinal Stents

According to IMARC Group’s latest research report, titled “Gastrointestinal Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, offers a comprehensive analysis of the industry, which comprises insights into the gastrointestinal stents market. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global gastrointestinal stents market size reached US$ 409.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 508.6 Million by 2028, exhibiting a growth rate (CAGR) of 3.5% during 2023-2028.

Gastrointestinal Stents Market Outlook:

Gastrointestinal stents represent artificial tube grafts that are inserted in the body to control blockages from cancerous tissues in the small intestines, gullet, and stomach. Some of the common product types include biliary, duodenal, colonic, pancreatic, esophageal, etc. These gastrointestinal stents are expandable and aim to remove obstructions and reduce the pressure caused by inflammation and allow the patients to lead a normal life. Consequently, they find extensive applications in hospitals, specialty clinics, ambulatory surgical centers, etc.

Get Free Sample Copy of Report at –

Gastrointestinal Stents Market Growth:

The growing prevalence of colorectal cancer across countries and the expanding geriatric population suffering from gastrointestinal diseases, including bowel ailments, diverticulosis, and gastrointestinal malignancies, are primarily driving the gastrointestinal stents market. Apart from this, the shifting preferences among patients and medical practitioners toward minimally invasive (MI) surgical procedures that involve low risk of infections, less scarring and pain, quick recuperation period, and minimal loss of blood as compared to traditional methods are also positively influencing the global market. Moreover, the inflating expenditure on research and development (R&D) activities for technological advancements and the introduction of bio-absorbable and nitinol material-based stents that offer a high degree of flexibility and kink resistance are acting as significant growth-inducing factors. In line with this, the development of biodegradable, drug-eluting, and radioactive stents is further augmenting the market growth. In addition to this, the increasing strategic collaboration among key market players and the launch of numerous favorable policies by government bodies, especially in developing countries, to improve healthcare infrastructure are projected to bolster the gastrointestinal stents market over the forecasted period.

Key Market Segmentation:

Competitive Landscape:

  • Becton
  • Dickinson and Company
  • Boston Scientific Corporation
  • Cantel Medical Corporation
  • Conmed Corporation
  • Cook Group Incorporated
  • S.R.O.
  • Hobbs Medical Inc.
  • Merit Medical Systems Inc.
  • Olympus Corporation
  • Taewoong Medical Co. Ltd.

Breakup by Product Type:

  • Biliary Stents
  • Duodenal Stents
  • Colonic Stents
  • Pancreatic Stents
  • Esophageal Stents

Breakup by Technology Type:

  • Anti-Migratory Stents
  • Drug-Eluting Stents
  • Radioactive Stents
  • Anti-Reflux Stents
  • Shape-Modified Stents
  • Others

Breakup by Material:

  • Plastic Stents
  • Self-Expanding Metal Stents
    • Stainless Steel Stents
    • – Nitinol Stents
    • – Others
  • Covered Self-Expandable Metallic Stents
  • Biodegradable or Drug Eluting Stents

Breakup by End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:


134 N 4th St. Brooklyn, NY 11249, USA


Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply

Your email address will not be published. Required fields are marked *